Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: supplementary analysis of a phase II trial (JCOG0706S1).
Imamura Y, Kiyota N, Ogawa G, Akimoto T, Fujii M, Hanai N, Iwae S, Monden N, Matsuura K, Onozawa Y, Hayashi R, Tahara M; Japan Clinical Oncology Group (JCOG) Head and Neck Cancer Study Group. Imamura Y, et al. Among authors: ogawa g. Jpn J Clin Oncol. 2019 Dec 18;49(11):1009-1015. doi: 10.1093/jjco/hyz121. Jpn J Clin Oncol. 2019. PMID: 31665358 Clinical Trial.
Final report of survival and late toxicities in the Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702).
Onimaru R, Onishi H, Ogawa G, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Shirato H. Onimaru R, et al. Among authors: ogawa g. Jpn J Clin Oncol. 2018 Dec 1;48(12):1076-1082. doi: 10.1093/jjco/hyy141. Jpn J Clin Oncol. 2018. PMID: 30277519 Free PMC article. Clinical Trial.
The association of primary tumor site with acute adverse event and efficacy of definitive chemoradiotherapy for cStage II/III esophageal cancer: an exploratory analysis of JCOG0909.
Hironaka S, Komori A, Machida R, Ito Y, Takeuchi H, Ogawa G, Kato K, Onozawa M, Minashi K, Yano T, Nakamura K, Tsushima T, Hara H, Nozaki I, Ura T, Chin K, Fukuda H, Kitagawa Y. Hironaka S, et al. Among authors: ogawa g. Esophagus. 2020 Oct;17(4):417-424. doi: 10.1007/s10388-020-00741-w. Epub 2020 Apr 28. Esophagus. 2020. PMID: 32342253 Clinical Trial.
Second primary cancers and recurrence in patients after resection of colorectal cancer: An integrated analysis of trials by Japan Clinical Oncology Group: JCOG1702A.
Tanaka K, Ogawa G, Mizusawa J, Kadota T, Nakamura K, Shimada Y, Hamaguchi T, Fujita S, Kitano S, Inomata M, Kanemitsu Y, Fukuda H; Colorectal Cancer Study Group of Japan Clinical Oncology Group (JCOG). Tanaka K, et al. Among authors: ogawa g. Jpn J Clin Oncol. 2021 Feb 8;51(2):185-191. doi: 10.1093/jjco/hyaa184. Jpn J Clin Oncol. 2021. PMID: 33157551
Stage III disease of ovarian, tubal and peritoneal cancers can be accurately diagnosed with pre-operative CT. Japan Clinical Oncology Group Study JCOG0602.
Onda T, Tanaka YO, Kitai S, Manabe T, Ishikawa M, Hasumi Y, Miyamoto K, Ogawa G, Satoh T, Saito T, Kasamatsu T, Nakanishi T; Japan Clinical Oncology Group. Onda T, et al. Among authors: ogawa g. Jpn J Clin Oncol. 2021 Feb 8;51(2):205-212. doi: 10.1093/jjco/hyaa145. Jpn J Clin Oncol. 2021. PMID: 33556170 Clinical Trial.
Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemic inflammatory response in JCOG1106.
Mizuno N, Ioka T, Ogawa G, Nakamura S, Hiraoka N, Ito Y, Katayama H, Takada R, Kobayashi S, Ikeda M, Miwa H, Okano N, Kuramochi H, Sekimoto M, Okusaka T, Ozaka M, Todaka A, Gotoh K, Tobimatsu K, Yamaguchi H, Nakagohri T, Kajiura S, Sudo K, Okamura K, Shimizu S, Shirakawa H, Kato N, Sano K, Iwai T, Fujimori N, Ueno M, Ishii H, Furuse J; Hepatobiliary and Pancreatic Oncology Group (HBPOG) of Japan Clinical Oncology Group (JCOG). Mizuno N, et al. Among authors: ogawa g. Jpn J Clin Oncol. 2023 Jul 31;53(8):704-713. doi: 10.1093/jjco/hyad044. Jpn J Clin Oncol. 2023. PMID: 37248668 Free PMC article. Clinical Trial.
Factors associated with technical difficulty of endoscopic submucosal dissection for early gastric cancer that met the expanded indication criteria: post hoc analysis of a multi-institutional prospective confirmatory trial (JCOG0607).
Yano T, Hasuike N, Ono H, Boku N, Ogawa G, Kadota T, Oda I, Doyama H, Hori S, Iishi H, Takahashi A, Takizawa K, Muto M. Yano T, et al. Among authors: ogawa g. Gastric Cancer. 2020 Jan;23(1):168-174. doi: 10.1007/s10120-019-00991-3. Epub 2019 Jul 18. Gastric Cancer. 2020. PMID: 31321630 Clinical Trial.
Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial.
Onda T, Satoh T, Ogawa G, Saito T, Kasamatsu T, Nakanishi T, Mizutani T, Takehara K, Okamoto A, Ushijima K, Kobayashi H, Kawana K, Yokota H, Takano M, Kanao H, Watanabe Y, Yamamoto K, Yaegashi N, Kamura T, Yoshikawa H; Japan Clinical Oncology Group. Onda T, et al. Among authors: ogawa g. Eur J Cancer. 2020 May;130:114-125. doi: 10.1016/j.ejca.2020.02.020. Epub 2020 Mar 13. Eur J Cancer. 2020. PMID: 32179446 Clinical Trial.
108 results